TRIDENT LIFELINE
Back to All Ratios
|
TRIDENT LIFELINE Last 5 Year EV/CE History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | |
---|---|---|---|
EV/CE(x) | 2.89 | 3.36 | 0.80 |
What is the latest EV/CE ratio of TRIDENT LIFELINE ?
Year | EV/CE |
---|---|
Mar2024 | 2.89 |
Mar2023 | 3.36 |
Mar2022 | 0.80 |
How is EV/CE of TRIDENT LIFELINE Trending?
Years | EV/CE | % Change | |
---|---|---|---|
Mar2024 | 2.89 | -13.99 | |
Mar2023 | 3.36 | 320.00 | |
Mar2022 | 0.8 | - |
Other Financial Ratios of TRIDENT LIFELINE
Operational & Financial Ratios Earnings Per Share CEPS DPS Book NAV/Share Tax Rate | Margin Ratios Core EBITDA Margin EBIT Margin Pre Tax Margin PAT Margin Cash Profit Margin | Performance Ratios ROA ROE ROCE Asset Turnover Sales/Fixed Asset Working Capital/Sales | Efficiency Ratios Fixed Capital/Sales Receivable days Inventory Days Payable days | Valuation Parameters PER PCE Price/Book Yield EV/Net Sales EV/Core EBITDA EV/EBIT M Cap / Sales | Growth Ratios Net Sales Growth Core EBITDA Growth EBIT Growth PAT Growth EPS Growth | Financial Stability Ratios Total Debt/Equity Current Ratio Quick Ratio Interest Cover Total Debt/Mcap |
Compare EV/CE ratio of peers of TRIDENT LIFELINE
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
TRIDENT LIFELINE | ₹313.2 Cr | -7.5% | 1.8% | 78.6% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹391,667.0 Cr | 1.2% | -4.2% | -5.7% | Stock Analytics | |
DIVIS LABORATORIES | ₹163,697.0 Cr | 3% | -9.1% | 31.5% | Stock Analytics | |
CIPLA | ₹126,365.0 Cr | 4.1% | 5.5% | -0.1% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹123,639.0 Cr | 1.1% | 4.3% | 8.2% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹105,479.0 Cr | 3.7% | 0.1% | -7.4% | Stock Analytics |
TRIDENT LIFELINE Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
TRIDENT LIFELINE | -7.5% |
1.8% |
78.6% |
SENSEX | 1.8% |
-1.7% |
2.9% |
You may also like the below Video Courses